SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001835567-23-000022
Filing Date
2023-04-10
Accepted
2023-04-10 16:36:29
Documents
14
Period of Report
2023-04-10
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K pear-20230410.htm   iXBRL 8-K 31552
6 pear-20230410_g1.jpg GRAPHIC 650556
  Complete submission text file 0001835567-23-000022.txt   1728151

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pear-20230410.xsd EX-101.SCH 2310
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pear-20230410_def.xml EX-101.DEF 16514
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pear-20230410_lab.xml EX-101.LAB 31940
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pear-20230410_pre.xml EX-101.PRE 17267
8 EXTRACTED XBRL INSTANCE DOCUMENT pear-20230410_htm.xml XML 6045
Mailing Address 200 STATE STREET 13TH FLOOR BOSTON MA 02109
Business Address 200 STATE STREET 13TH FLOOR BOSTON MA 02109 6469322774
Pear Therapeutics, Inc. (Filer) CIK: 0001835567 (see all company filings)

IRS No.: 854103092 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39969 | Film No.: 23811527
SIC: 8000 Services-Health Services